Global Public Health Partnering 2010-2017: Deal trends, players and financials

Publisher Name :
Date: 01-Nov-2017
No. of pages: 1000
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Global Public Health Partnering 2010 to 2017 provides the full collection of Public Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in Public Health partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Public Health partnering agreement structure

Public Health partnering contract documents

Top Public Health deals by value

Most active Public Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Public Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Public Health deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2010. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Public Health technologies and products.

Report scope

Global Public Health Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Public Health trends and structure of deals entered into by leading companies worldwide.

Global Public Health Partnering 2010 to 2017 includes:

Trends in Public Health dealmaking in the biopharma industry since 2010

Analysis of Public Health deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Public Health deal contract documents

Comprehensive access to over 3500 Public Health deal records

The leading Public Health deals by value since 2010

Most active Public Health dealmakers since 2010

The report includes deals for the following indications: Addiction, Smoking, Drugs, Alcohol, Health education, Obesity, Preventative medicine, plus other public health indications.

In Global Public Health Partnering 2010 to 2017, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Public Health Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 200 public health deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Key benefits

Global Public Health Partnering 2010 to 2017 provides the reader with the following key benefits:

In-depth understanding of Public Health deal trends since 2010

Access Public Health deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Public Health partner companies

Comprehensive access to over 750 links to actual Public Health deals entered into by the world's biopharma companies

Indepth review of Public Health deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Public Health opportunities

Uncover companies actively partnering Public Health opportunities

Global Public Health Partnering 2010-2017: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Public Health dealmaking
2.1. Introduction
2.2. Public Health partnering over the years
2.3. Public Health partnering by deal type
2.4. Public Health partnering by industry sector
2.5. Public Health partnering by stage of development
2.6. Public Health partnering by technology type
2.7. Public Health partnering by therapeutic indication

Chapter 3 -Financial deal terms for Public Health partnering
3.1. Introduction
3.2. Disclosed financials terms for Public Health partnering
3.3. Public Health partnering headline values
3.4. Public Health deal upfront payments
3.5. Public Health deal milestone payments
3.6. Public Health royalty rates

Chapter 4 - Leading Public Health deals and dealmakers
4.1. Introduction
4.2. Most active in Public Health partnering
4.3. List of most active dealmakers in Public Health
4.4. Top Public Health deals by value

Chapter 5 - Public Health contract document directory
5.1. Introduction
5.2. Public Health partnering deals where contract document available

Chapter 6 - Public Health dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Public Health therapeutic target

Appendices

Appendix 1 - Directory of Public Health deals by company A-Z 2010 to 2017
Appendix 2 - Directory of Public Health deals by deal type 2010 to 2017
Appendix 3 - Directory of Public Health deals by stage of development 2010 to 2017
Appendix 4 - Directory of Public Health deals by technology type 2010 to 2017
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Figures

Figure 1: Public Health partnering since 2010
Figure 2: Public Health partnering by deal type since 2010
Figure 3: Public Health partnering by industry sector since 2010
Figure 4: Public Health partnering by stage of development since 2010
Figure 5: Public Health partnering by technology type since 2010
Figure 6: Public Health partnering by indication since 2010
Figure 7: Public Health deals with a headline value
Figure 8: Public Health deals with upfront payment values
Figure 9: Public Health deals with milestone payment
Figure 10: Public Health deals with royalty rates
Figure 11: Active Public Health dealmaking activity- 2010 to 2017
Figure 12: Top Public Health deals by value since 2010
  • North America Cardiac Care Medical Equipment Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 121
    Cardiac Care Medical Equipment is the equipment used for cardiac care. The robust line of cardiac care products include Cardiac Monitors, EKG (Electrocardiogram) Equipment, Heart-Lung Bypass Machines, Stress Test Systems, Intra-Aortic Balloon Pumps, Infusion Pumps, AEDs and Defibrillators, and more. Scope of the Report: This report focuses on the Cardiac Care Medical Equipment in North America market, especially in United States, Canada and Mexico. This report categorizes t......
  • North America Cochlear Implant (CI) System Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 115
    A Cochlear Implant (CI) System is a small, complex electronic device that can help to provide a sense of sound to a person who is profoundly deaf or severely hard-of-hearing. The implant consists of an external portion that sits behind the ear and a second portion that is surgically placed under the skin. Scope of the Report: This report focuses on the Cochlear Implant (CI) System in North America market, especially in United States, Canada and Mexico. This report categoriz......
  • North America Hospital Furniture Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 121
    Hospital Furniture is the Furniture specially designed for hospital use. Hospital furniture along with modern medical equipment have important role to play in health care. They not only help surgeons to perform the critical surgery with utmost safety of patient, but also make patients feel comfortable during their stay in hospital or the surgery/post-surgery as well. Scope of the Report: This report focuses on the Hospital Furniture in North America market, especially in Un......
  • North America Ibuprofen Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 115
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Scope of the Report: This report focuses on the Ibuprofen in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Mark......
  • EMEA Prostate Cancer Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 119
    "The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and......
  • EMEA Vacuum Blood Collection Tube Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 121
    A Vacuum Blood Collection Tube blood collection tube is a sterile glass or plastic tube with a closure that is evacuated to create a vacuum inside the tube facilitating the draw of a predetermined volume of liquid. Most commonly used to collect blood samples in venipuncture, they are also used as urine collection tubes and as serum separator tubes. Vacuum Blood Collection Tube tubes may contain additives designed to stabilize and preserve the specimen prior to analytical testing. Tubes are avail......
  • EMEA Stent Grafts Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 16-Nov-2017        Price: US 4480 Onwards        Pages: 123
    A stent graft or covered stent is type of vascular stent with a fabric coating that creates a contained tube but is expandable like a bare metal stent. Covered stents are used in endovascular surgical procedures such as endovascular aneurysm repair. Stent grafts are also used to treat stenosis in vascular grafts and fistulas used for hemodialysis. Scope of the Report: This report focuses on the Stent Grafts in EMEA market, covering Europe, Middle East and Africa, This repor......
  • Global Behavioral Rehabilitation Market Professional Survey Report 2017
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 107
    This report studies Behavioral Rehabilitation in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Acadia Healthcar - Universal Health Services - Magellan Health......
  • Global and China Contract Research Organization (CRO) Market Research by Company, Type & Application 2013-2025
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 88
    Summary Market Segment as follows: By Type - Preclinical CRO - Clinical Trial CRO By Application - Biotechnology - Medical Device Industry By Company - Quintiles - LabCorp (Covance) - PPD - Parexel - ICON - PRA - inVentiv - INC - CRL - Wuxi AppTec The main contents of the report including: Section 1: Product def......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs